139 related articles for article (PubMed ID: 35530903)
21. Pseudohypoaldosteronism Type 1 Newborn Patient with a Novel Mutation in
Seyhanli M; Ilhan O; Gumus E; Bor M; Karaca M
J Pediatr Intensive Care; 2020 Jun; 9(2):145-148. PubMed ID: 32351772
[TBL] [Abstract][Full Text] [Related]
22. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
[TBL] [Abstract][Full Text] [Related]
23. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.
Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534
[TBL] [Abstract][Full Text] [Related]
24. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
[TBL] [Abstract][Full Text] [Related]
25. Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B.
Saffari F; Bahadoran E; Homaei A; Moghbelinejad S
J Pediatr Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38963175
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
[TBL] [Abstract][Full Text] [Related]
27. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
Riepe FG; Holterhus PM
Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
[TBL] [Abstract][Full Text] [Related]
28. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
[TBL] [Abstract][Full Text] [Related]
30. Pseudohypoaldosteronisms, report on a 10-patient series.
Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
[TBL] [Abstract][Full Text] [Related]
31. Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.
Adachi M; Asakura Y; Muroya K; Tajima T; Fujieda K; Kuribayashi E; Uchida S
Clin Exp Nephrol; 2010 Jun; 14(3):228-32. PubMed ID: 20376516
[TBL] [Abstract][Full Text] [Related]
32. Pseudohypoaldosteronism type 1: management issues.
Sharma R; Pandey M; Kanwal SK; Zennaro MC
Indian Pediatr; 2013 Mar; 50(3):331-3. PubMed ID: 23680607
[TBL] [Abstract][Full Text] [Related]
33. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
[TBL] [Abstract][Full Text] [Related]
34. Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the alpha subunit of the epithelial sodium channel.
Riepe FG; van Bemmelen MX; Cachat F; Plendl H; Gautschi I; Krone N; Holterhus PM; Theintz G; Schild L
Clin Endocrinol (Oxf); 2009 Feb; 70(2):252-8. PubMed ID: 18547339
[TBL] [Abstract][Full Text] [Related]
35. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
[TBL] [Abstract][Full Text] [Related]
36. Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.
Kanda K; Nozu K; Yokoyama N; Morioka I; Miwa A; Hashimura Y; Kaito H; Iijima K; Matsuo M
BMC Nephrol; 2009 Nov; 10():37. PubMed ID: 19912655
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of renal pseudohypoaldosteronism type 1.
Riepe FG
Expert Rev Endocrinol Metab; 2007 May; 2(3):407-419. PubMed ID: 30743803
[TBL] [Abstract][Full Text] [Related]
38. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families.
Strautnieks SS; Thompson RJ; Gardiner RM; Chung E
Nat Genet; 1996 Jun; 13(2):248-50. PubMed ID: 8640238
[TBL] [Abstract][Full Text] [Related]
39. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1.
Ekinci Z; Aytac MB; Cheong HI
J Pediatr Endocrinol Metab; 2013; 26(11-12):1197-200. PubMed ID: 23813355
[TBL] [Abstract][Full Text] [Related]
40. Critical points in the management of pseudohypoaldosteronism type 1.
Güran T; Değirmenci S; Bulut İK; Say A; Riepe FG; Güran Ö
J Clin Res Pediatr Endocrinol; 2011; 3(2):98-100. PubMed ID: 21750640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
